MSB 4.66% $1.46 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,971 Posts.
    lightbulb Created with Sketch. 637
    Isn’t that inter-relationship evident?
    Low potency would mean low survival rates and high potency …higher survival rates….over time periods that were shown today ….out to 4 years
    Last edited by stocksa: 23/11/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.065(4.66%)
Mkt cap ! $1.667B
Open High Low Value Volume
$1.41 $1.50 $1.40 $5.699M 3.943M

Buyers (Bids)

No. Vol. Price($)
5 122380 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.46 11015 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.